116 related articles for article (PubMed ID: 27714846)
21. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer.
Qiu W; Zhou F; Zhang Q; Sun X; Shi X; Liang Y; Wang X; Yue L
APMIS; 2013 Oct; 121(10):919-25. PubMed ID: 23763304
[TBL] [Abstract][Full Text] [Related]
22. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of CRM1 in pancreas cancer.
Huang WY; Yue L; Qiu WS; Wang LW; Zhou XH; Sun YJ
Clin Invest Med; 2009 Dec; 32(6):E315. PubMed ID: 20003838
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
25. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
27. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of BCAT1 is a prognostic marker in gastric cancer.
Xu Y; Yu W; Yang T; Zhang M; Liang C; Cai X; Shao Q
Hum Pathol; 2018 May; 75():41-46. PubMed ID: 29447920
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of TMPRSS4 in gastric cancer.
Sheng H; Shen W; Zeng J; Xi L; Deng L
Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
Xu Y; Shao QS; Yao HB; Jin Y; Ma YY; Jia LH
Histopathology; 2014 Jun; 64(7):963-70. PubMed ID: 24329718
[TBL] [Abstract][Full Text] [Related]
31. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
[TBL] [Abstract][Full Text] [Related]
32. High TREM2 expression correlates with poor prognosis in gastric cancer.
Zhang X; Wang W; Li P; Wang X; Ni K
Hum Pathol; 2018 Feb; 72():91-99. PubMed ID: 29104108
[TBL] [Abstract][Full Text] [Related]
33. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma.
Chen J; Sun J; Yang L; Yan Y; Shi W; Shi J; Huang Q; Chen J; Lan Q
Biochem Biophys Res Commun; 2015 Oct; 466(1):124-30. PubMed ID: 26343305
[TBL] [Abstract][Full Text] [Related]
35. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
36. Elevated epiregulin expression predicts poor prognosis in gastric cancer.
Xia Q; Zhou Y; Yong H; Wang X; Zhao W; Ding G; Zhu J; Li X; Feng Z; Wang B
Pathol Res Pract; 2019 May; 215(5):873-879. PubMed ID: 30738695
[TBL] [Abstract][Full Text] [Related]
37. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
Qi W; Yang Z; Li H; Cui Y; Xuan Y
APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
[TBL] [Abstract][Full Text] [Related]
38. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
39. The expression of CRM1 is associated with prognosis in human osteosarcoma.
Yao Y; Dong Y; Lin F; Zhao H; Shen Z; Chen P; Sun YJ; Tang LN; Zheng SE
Oncol Rep; 2009 Jan; 21(1):229-35. PubMed ID: 19082467
[TBL] [Abstract][Full Text] [Related]
40. Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
Yang Y; Li M; Yan Y; Zhang J; Sun K; Qu JK; Wang JS; Duan XY
Oncol Rep; 2015 Nov; 34(5):2385-94. PubMed ID: 26329876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
